ARKEMA/S (OTCMKTS:ARKAY) Upgraded to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of ARKEMA/S (OTCMKTS:ARKAY) from a hold rating to a buy rating in a report published on Tuesday morning, reports. Zacks Investment Research currently has $99.00 target price on the basic materials company’s stock.

According to Zacks, “Arkema SA is engaged in the manufacturing and marketing of vinyl products, industrial chemicals, and performance products. Vinyl products include chlorine or caustic soda, pipes and profiles, PVC, and vinyl compounds. Industrial chemicals include emulsion systems, fluorochemicals, hydrogen peroxide, PMMA and methacrylics, specialty acrylic polymers and thiochemicals. Performance products include functional additives, specialty chemicals and technical polymers. The Company’s products can be used for various purposes including air conditioning or refrigeration; chemical processing, coating, construction; packaging; automotive & transportation. Its products, also find their application in adhesives and sealants, agriculture & agrochemicals, consumer goods, electronics, foams, solvents and aerosols market, health, hygiene & beauty, oil & gas, energy, pharmaceuticals, pulp & paper, rubber market, sports & leisure, etc. Arkema SA is headquartered in France. “

Other analysts have also issued reports about the company. ValuEngine raised Zumiez from a sell rating to a hold rating in a research note on Saturday, March 30th. Berenberg Bank reissued a buy rating and set a GBX 3,620 ($47.30) price target on shares of Bellway in a research note on Wednesday, April 3rd. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of Hold and an average target price of $99.00.

Shares of ARKAY stock opened at $89.51 on Tuesday. The company’s 50-day moving average price is $88.27. ARKEMA/S has a 12 month low of $82.00 and a 12 month high of $131.55. The firm has a market capitalization of $6.87 billion, a price-to-earnings ratio of 7.98, a price-to-earnings-growth ratio of 2.20 and a beta of 1.34. The company has a quick ratio of 1.75, a current ratio of 2.42 and a debt-to-equity ratio of 0.45.

ARKEMA/S (OTCMKTS:ARKAY) last announced its quarterly earnings results on Tuesday, May 7th. The basic materials company reported $2.45 EPS for the quarter. ARKEMA/S had a return on equity of 13.83% and a net margin of 7.55%. The firm had revenue of $2.52 billion for the quarter. As a group, analysts forecast that ARKEMA/S will post 9.24 EPS for the current year.

The company also recently declared an annual dividend, which was paid on Thursday, June 13th. Stockholders of record on Friday, May 24th were paid a dividend of $2.353 per share. This represents a dividend yield of 2.61%. The ex-dividend date was Thursday, May 23rd. ARKEMA/S’s payout ratio is 20.87%.


Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. It operates through three segments: High Performance Materials, Industrial Specialties, and Coating Solutions. Its products include acrylics, coating resins, electroactive polymers, fluorochemicals, fluoropolymers, functional polyolefins, hydrazine hydrate, hydrogen peroxide, molecular sieves, organic peroxide, oxygenated solvents, poly-ether-ketone-ketone polyetherketoneketone, plastic additives, polymethyl methacrylate resins and sheets, rheology additives, solutions for glass coating, specialty adhesives, specialty polyamides, surfactants and additives, technical fluids, and thiochemicals.

Featured Article: Is a Roth IRA right for you?

Get a free copy of the Zacks research report on ARKEMA/S (ARKAY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for ARKEMA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARKEMA/S and related companies with's FREE daily email newsletter.